TOR1AIP1 anticorps (AA 275-325)

N° du produit ABIN1943334

Cet anticorps anti-TOR1AIP1 Polyclonal Lapin (ABIN1943334) détecte spécifiquement TOR1AIP1 dans IHC, IF et IHC (p). L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour TOR1AIP1 anticorps (AA 275-325) (ABIN1943334)

Antigène: TOR1AIP1 (Torsin A Interacting Protein 1 (TOR1AIP1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TOR1AIP1 est non-conjugé

Application: Immunohistochemistry (IHC), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-TOR1AIP1 anticorps

Épitope: AA 275-325

Specificité: Region between residue 275 and 325 of human lamina associated polypeptide 1B using the numbering given in entry NP_056417.2 (GeneID 26092).

Purification: Affinity purified

Isotype: IgG

Information d'application

Indications d'application: Approved: IF (1:50 - 1:500), IHC, IHC-P (1:100 - 1:500)

Usage: Immunohistochemistry: Antigen retrieval is recommended. Antigen retrieval with citrate buffer will enhance staining. Likely to work with frozen sections. In some cases, the antibody may be diluted further than indicated. Human controls: Breast Carcinoma, Colon Carcinoma.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Store at 2-8°C for up to 1 year.

Date de péremption: 12 months

Détails sur TOR1AIP1

Antigène: TOR1AIP1 (Torsin A Interacting Protein 1 (TOR1AIP1))

Autre désignation: TOR1AIP1 / LAP1

Sujet: Name/Gene ID: TOR1AIP1

Synonyms: TOR1AIP1, LAP1B, Lamin-associated protein 1B, LAP1, Torsin A interacting protein 1

ID gène: 26092

Pathways: SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2